Cargando…

Cholesterol, Statins, and Alzheimer Disease

Detalles Bibliográficos
Autores principales:	Koudinov, Alexei R, Berezov, Temirbolat T
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2005
Materias:	Correspondence and Other Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1069670/ https://www.ncbi.nlm.nih.gov/pubmed/15783263 http://dx.doi.org/10.1371/journal.pmed.0020081

Ejemplares similares

Photodynamic Therapy for Gynecological Diseases and Breast Cancer
por: Shishkova, Natashis, et al.
Publicado: (2012)

Accounting for Individual Differences in Risk of Alzheimer Disease
por: Grant, William
Publicado: (2005)

Alzheimer's Disease: cholesterol, membrane rafts, isoprenoids and statins
por: Reid, Patrick C, et al.
Publicado: (2007)

Cholesterol suppresses antimicrobial effect of statins
por: Haeri, Mohammad Reza, et al.
Publicado: (2015)

Hypolipidemia and Sepsis: It is The Hypolipidemia Not The Statins
por: Elmehdawi, RR
Publicado: (2008)

Statin therapy for venous ulcers
por: Dickerson, JE, et al.
Publicado: (2015)

Statin Responses in Chinese Patients
por: Tomlinson, Brian, et al.
Publicado: (2018)

Statin Intolerance—An Asian Perspective
por: Tomlinson, Brian, et al.
Publicado: (2020)

Statin Intolerance Clinical Guide 2018
por: Kajinami, Kouji, et al.
Publicado: (2020)

Impact of statins on risk and survival of ovarian cancer
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2015)

Questionable Advertising of Psychotropic Medications and Disease Mongering
por: Lacasse, Jeffrey R, et al.
Publicado: (2006)

Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma
por: Yi, Sang-Wook, et al.
Publicado: (2019)

Statins: Cholesterol guidelines and Indian perspective
por: Menon, Anil S., et al.
Publicado: (2015)

Confessions of a Disease Monger
por: Phelps, James
Publicado: (2006)

Defining Disease in the Information Age
por: Amaral, Olavo B
Publicado: (2006)

Disease Mongering: One of the Hidden Consequences
por: Gillman, Kenneth
Publicado: (2006)

The Need of a Neonatal Preparation for Chagas Disease
por: Sosa-Estani, Sergio, et al.
Publicado: (2005)

The Newest Mania: Seeing Disease Mongering Everywhere
por: Ghaemi, S. Nassir
Publicado: (2006)

There Is No Such Thing as a Psychiatric Disorder/Disease/Chemical Imbalance
por: Baughman, Fred
Publicado: (2006)

Fairness Creams in South Asia—A Case of Disease Mongering?
por: Shankar, P. Ravi, et al.
Publicado: (2006)

Taiwan's Potential to Assist Developing Countries to Combat Infectious Diseases
por: Agoramoorthy, Govindasamy, et al.
Publicado: (2006)

Fundamental Limits to the Precision of Early Warning Systems for Epidemics of Infectious Diseases
por: Drake, John M
Publicado: (2005)

Awareness and Attitudes about Disease Mongering among Medical and Pharmaceutical Students
por: Kumar, C. Jairaj, et al.
Publicado: (2006)

Response from Savioli and Colleagues from the Department of Neglected Tropical Diseases, World Health Organization
por: Savioli, Lorenzo, et al.
Publicado: (2006)

An association of ABCG8: rs11887534 polymorphism and HDL-cholesterol response to statin treatment in the Polish population
por: Sałacka, A., et al.
Publicado: (2021)

Cholesterol: a Century of Research and Debate
por: Mathew, BC, et al.
Publicado: (2008)

Long QT: Time to cut cholesterol?
por: Li, Jin, et al.
Publicado: (2023)

Repurposing cholesterol lowering drugs in the treatment and management of monkeypox
por: Sekaran, Saravanan, et al.
Publicado: (2023)

The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein Cholesterol
por: Al-Sabti, Hilal, et al.
Publicado: (2022)

Anticoagulation, Statins and “Arterial Thrombotic Sequalae after Covid-19: Mind the Gap”
por: Ilonzo, Nicole, et al.
Publicado: (2021)

Statins redux: A re-assessment of how statins lower plasma cholesterol
por: Raghow, Rajendra
Publicado: (2017)

Cholesterol and hepatocellular carcinoma risk: reliable and actionable?
por: Braillon, Alain
Publicado: (2021)

Risk of Coronary Artery Disease Conferred by Low-Density Lipoprotein Cholesterol Depends on Polygenic Background
por: Bolli, Alessandro, et al.
Publicado: (2021)

From Angiopoietin-2 to basic chemistry: differential effects of statins on endothelial homeostasis in ARDS
por: Hofmaenner, Daniel A., et al.
Publicado: (2023)

Racial Differences in the Cholesterol-Lowering Effect of Statin
por: Naito, Ryo, et al.
Publicado: (2017)

Asialoglycoprotein receptor 1 gene expression in peripheral blood monocytes associates with serum total cholesterol and low-density lipoprotein cholesterol levels
por: Zhao, Xiang, et al.
Publicado: (2020)

Forecasting Cholesterol Management-End of the Statin Gold Rush?
por: Crownover, Brian K., et al.
Publicado: (2006)

Destination Memory in Mild Alzheimer’s Disease
por: El Haj, Mohamad, et al.
Publicado: (2013)

Oxidized Low-Density Lipoprotein Cholesterol and the Ratio in the Diagnosis and Evaluation of Therapeutic Effect In Patients with Coronary Artery Disease
por: Huang, Huiling, et al.
Publicado: (2012)

Authors' Reply
por: Lacasse, Jeffrey R, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_049pq1h550t05ob3qqboleh4pk